---
title: CovarsaDx vs Quanticate
slug_a: covarsadx
slug_b: quanticate
site: cro
review_signal_gate: closed
canonical_path: /compare/covarsadx/quanticate
generated_by: BioBM Editorial AI
---

# CovarsaDx vs Quanticate

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

CovarsaDx (covarsadx) is listed for cro. CovarsaDx provides full-service clinical research, regulatory consulting, and quality assurance for IVD and medical device trials, with expertise in FDA 510(k), De Novo, and PMA pathways.

Services: 4. Modalities: 0. Indications: 0. Locations: 0. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (4).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Quanticate (quanticate) is listed for cro. Quanticate is a biometrics CRO with 30 years of expertise in biostatistics, clinical data management, and pharmacovigilance across all clinical trial phases. The company specializes in statistical protocol design, CDISC standards compliance, and real-world data analysis to support regulatory submissions.

Services: 6. Modalities: 0. Indications: 0. Locations: 8. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in locations (8).

Review summary: Review summary withheld until site-level review gate opens.